CW September 2006
Volume 15Issue Number 9 September 2006 ISSN 10593802 Personalized Vaccine Trial for Lung CancerNorthwest Biotherapeutics has received clearance from FDA to launch a phase I trial for lung cancer patients with a personalized cancer vaccine.
Go to Previous Page Go to Next Page Source & Additional Reading Northwest Biotherapeutics Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW September 2006Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
